Clinical Trial Detail

NCT ID NCT03697304
Title Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours.
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim

gastric adenocarcinoma

Advanced Solid Tumor

gastroesophageal adenocarcinoma


BI 754091

BI 754111

Age Groups: senior adult

No variant requirements are available.